PhaseBio Pharmaceuticals, Inc. (PHAS)
Income Before Tax
$26.50M
TTM · Period ending: · USD
PHAS Income Before Tax
Latest reported$26.50Mperiod ending
Latest reported$26.50Mperiod ending
PHAS TTM Pre-Tax Income (-$16.17M → $26.50M)
TTM income before tax
High-resolution chart · PNG
PHAS income before tax history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Income Before Tax (USD) |
|---|---|
| 26,501,529 | |
| 16,087,529 | |
| -129,471 | |
| -116,736,000 | |
| -109,955,000 | |
| -111,018,000 | |
| -98,565,000 | |
| -79,521,000 | |
| -65,769,000 | |
| -46,859,000 | |
| -39,247,000 | |
| -32,784,000 | |
| -29,294,000 | |
| -26,736,000 | |
| -23,846,000 | |
| -21,513,000 | |
| -16,172,000 |